EKF Diagnostics Holdings plc
LSE: EKF.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Gavin Joseph Jones
- Employees
- 303
- Headquarters
- Cardiff, United Kingdom
- IPO year
- 2000
- Market cap
- £107.6M
- Website
- https://www.ekfdiagnostics.com
Loading EKF…
Loading profile data…Frequently asked questions about EKF
What does EKF Diagnostics Holdings plc (EKF.L) do?
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides...
Where does EKF.L trade?
EKF Diagnostics Holdings plc (EKF.L) trades on the London Stock Exchange.
What sector is EKF.L in?
EKF Diagnostics Holdings plc (EKF.L) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of EKF Diagnostics Holdings plc?
Gavin Joseph Jones is the chief executive officer of EKF Diagnostics Holdings plc (EKF.L).
Where is EKF Diagnostics Holdings plc headquartered?
EKF Diagnostics Holdings plc is headquartered in United Kingdom.
Does EKF.L pay a dividend?
EKF Diagnostics Holdings plc (EKF.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EKF.L go public?
EKF Diagnostics Holdings plc (EKF.L) completed its initial public offering in 2000.